Author Guidelines

IJD SUBMISSION FORMS

Online Submission
Contact the Editorial Office

1. ABOUT IJD

Published monthly, the International Journal of Dermatology (IJD) is specifically designed to provide dermatologists around the world with a regular, up-to-date source of information on all aspects of the diagnosis and management of skin diseases.

IJD’s longstanding interest in global dermatology and tropical skin diseases began upon its first issue release in the early 1960s. Today a well-established global presence, IJD showcases a comprehensive exploration into all aspects of dermatology as basic sciences, venereology and public health, and in teaching dermatology in developing countries. 

IJD is guided by a distinguished, international editorial board and emphasizes a global approach to continuing medical education for physicians and other providers of health care with a specific interest in problems relating to the skin.

2. MANUSCRIPT CATEGORIES

IJD invites the following types of submission:

Review Article
IJD welcomes the submission of both narrative reviews and systematic reviews with meta-analysis. 

Topics may include updates in clinically relevant basic science and cutaneous biology. These submissions must include an unstructured abstract (maximum 250 words). Tables, diagrams, and figures are preferred. Graphical abstracts, visually summarizing the key message and main results of the submission, are highly encouraged, though optional. The length of the body text should not exceed 5000 words (excluding the abstract, reference list and figures).

A list of multiple choice, true or false and/or open-ended questions may be listed at the end of the article to provide additional educational challenge to the reader. Answers will be made accessible on the Journal’s social media platforms. Keywords are a requirement, please see below for further details.

Narrative Review Articles summarize existing knowledge in a particular field, without appearing as exhaustive reviews of literature.

Systematic Review Articles with Meta-analysis function as synthesized summaries and critical appraisals that account for explicit questions through detailed and comprehensive literature searches in medicine.

The IJD does not currently consider nonmedical and bibliometric topics for publication under this manuscript type.

Original Article
As the primary means of communication, submitted Original Articles should present new data resulting from scientific research employing a broad variety of empirical methods and study protocols. These major didactic original articles should comprise the following structure: Abstract, Introduction, Materials and Methods, Results, Discussion and References. The length should not exceed 3000 words (excluding the abstract, reference list, figure and table legends), and preferably no more than 50 references. A structured abstract of approximately 250 words must be included and should consist of 4 paragraphs, labelled: Background, Methods, Results, and Conclusions. Graphical abstracts, visually summarizing the key message and main results of the submission, are encouraged, though optional. The authors can also include a Plain-language Summary (maximum 100 words) along with their submission. This supplemental excerpt is not mandatory, but it can enhance the visibility and citation of the article, while also reaching and benefitting a wider audience of readers. Keywords are a requirement, please see below for further details.

The IJD does not currently consider nonmedical and bibliometric topics for publication under this manuscript type.

Clinicopathological Challenge
Photographic essay that includes both a clinical and a pathological photograph in color. This contribution should not exceed 800 words in length, with a maximum of 2-3 figures or tables and 5 references. The submission should include a short unstructured abstract. The article must be formatted according to History, What’s the diagnosis? (providing four possibilities), Diagnosis, Discussion and References. Keywords are mandatory.

Correspondence Article: Clinical Correspondence & Letter to the Editor
Correspondence Articles should not exceed 600 words in length (excluding title, acknowledgement, and references), with a maximum of 5 references and 2 figures or tables. No abstracts and no supplemental materials are permitted. Case Reports can be submitted under the Clinical Correspondence manuscript type and should present detailed descriptions of symptoms, signs, diagnosis, treatment, and follow-up of unusual or novel occurrences. These submissions function as cornerstones of medical progress and provide new ideas and directions in research and medicine. A Letter to the Editor submission should present or respond to new findings in a brief and concise manner or serve as a short, standalone piece expressing an opinion. It may include a short acknowledgment, 1 or 2 sentences maximum.

The IJD does not currently consider nonmedical and bibliometric topics for publication under this manuscript type.

Viewpoint
A Viewpoint is a sharply focused critical analysis of a scientific issue of strong current interest within the field of dermatology. Viewpoints may address virtually any important topic relevant to the care of patients with dermatologic conditions or professional matters unique to dermatologists, e.g.: health law and policy, public health, clinical medicine, research and prevention, ethics. Viewpoints should provide differing views on a topic, backed up by literature and accompanied by carefully reasoned arguments and a conclusion. This contribution should not exceed 1200 words, with a maximum of 2-3 tables or figures and no more than 5 references.

On a Human Scale
Articles that relate to social, economic, cultural, artistic and humanitarian aspects of medicine. This contribution should not exceed 1200 words in length, with a maximum of 2 figures or tables and 5 references.
Updates in Medicine 
It is not essential that the contribution be heavily referenced but would be very helpful if pertinent and salient references were included, not only for documentation purposes, but also for additional reading. This contribution should not exceed 1200 words in length, with a maximum of 2 figures or tables and 5 references.
Education 
Articles about the methodology of curriculum and instruction in dermatology. This contribution should not exceed 1200 words in length, with a maximum of 2 figures or tables and 5 references.


Neglected Tropical Diseases
Any type of manuscripts dealing with neglected diseases and special problems encountered by dermatologists working in the tropics. The wordcount and the number of figures or tables may vary depending on manuscript type.

3. SUBMISSION OF MANUSCRIPTS

No Article Processing Charge (APC) applies to authors wanting to publish in the International Journal of Dermatology. Only when authors select the Open Access (OA) option will their submission become subject to an APC.

New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/IJD. You may check the status of your submission at any time by logging on to submission.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected]

Revised manuscripts must be submitted as revisions as directed by the Research Exchange website. Do not resubmit a revision as a new manuscript as this may result in re-review and considerable delay. The revision should be complete and contain all the tables and figures. Do not resubmit the original manuscript with your revision.

Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.

By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

 

Fast-Track Submission
IJD offers a fast-track process for a select number of high-priority ‘hot topic’ manuscripts containing time-sensitive data, e.g.: phase II or III RCTs. This mode of submission grants a first decision within 7 working days and a speedy revision process. Approval for fast track is entirely at the discretion of the Editor. There is no charge for the fast-track service, however, a pre-submission enquiry must be put forward at least 3 weeks before submission. The enquiry should include the abstract of the article and the reason for requesting fast track. To ensure a successful fast-track submission, authors must commit to responding attentively to reviewers’ comments and within a timely manner.

Please send all fast-track enquiries to [email protected].

4. PREPARATION OF MANUSCRIPTS

Manuscripts must be written in English and must comply with these instructions in every detail.

Text should be supplied in a word-processed format such as Microsoft Word for Windows. Charts and tables are considered textual and should be supplied in the same format. Figures (illustrations, diagrams, photographs) should be supplied in gif, jpeg, tif or eps format.

All manuscripts must be typed in 12 pt font with lines double spaced and margins of at least 2.5 cm.

Abbreviations must be defined when first used, both in the abstract and in the main text.

Manuscripts must be as succinct as possible. Text must comply with the word and figure limits defined in Section 2. If authors consider that a manuscript should not conform to the limits specified, exceptionally good reasons must be clearly provided in a cover letter accompanying the submission. Repetition of information or data in different sections of the manuscript must be carefully avoided.

Manuscripts should, where appropriate, include:

Title Page
The first page of all manuscripts should contain the following information:
1) the title of the paper
2) the full names of each author
3) ORCID number of the author(s)
4) name of the institution(s) at which the research was conducted
5) name, address, telephone number and email address of corresponding author
6) manuscript word count (excluding abstract and references), table and figure count
7) any conflict of interest disclosures (see Section 5)
8) a running head not exceeding 50 characters
9) a list of keywords


Abstracts

Authors submitting Original Articles should note that structured abstracts (maximum 250 words) are required. The structured abstract should adopt the format: Background, Methods, Results, Conclusions. In the case of Review Articles and CPC articles, unstructured abstracts must be provided upon submission (maximum 250 words/100 words).


Keywords
The selection of keywords is a crucial step in the submission process, as it is with the help of these phrases that a broad audience will discover the work. Therefore, the keywords accompanying each submission should be chosen carefully to allow ready retrieval of the study through various search engines. Every defining term that appears in the title must be designated as keyword also and as many keywords as necessary may be listed.

MeSH Tools provide adept assistance to authors seeking to elect the best possible keywords for their articles.


Text

This should in general, but not necessarily, be divided into sections with the headings: Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Table and figure legends. Figures should be submitted as separate files. The acknowledgements should include a statement of all funding sources that supported the work.

Please submit the full text of the manuscript, including the abstract, references, tables and legends as a single document. The title page may be included as page 1 of the main manuscript document or can be uploaded as a separate file but must be included.


Tables and Figures

Please consider our checklist before submitting tables and figures for your article.

Checklist for submitting figures:

  • Tables must not be inserted in the appropriate place in the text but should be included at the end of the manuscript, each on a separate page.
  • Figures (illustrations, diagrams, photographs) must be supplied in gif, jpeg, tif or eps format and submitted as separate original files.
  • All submitted figures must closely follow the preferred resolution guidelines for best presentation and aim for patient confidentiality, removing any identifying objects (clothing, footwear, body art etc.) from and around the individual(s) photographed.
  • Figure legends must be included as a separate section in your main text file.
  • All figures featured must be numbered in the order in which they appear.

Tables and figures should be referred to in text as follows: Fig. 1, Figs. 2–4; Table 1, Tables 2 and 3. The place at which a table or figure is to be inserted in the printed text should be indicated clearly on a manuscript. Each table and/or figure must have a legend that explains its purpose without reference to the text. Where a figure has more than one panel, each panel should be labelled in the top left-hand corner using lower case letters in parentheses i.e. ‘(a)’, ‘(b)’ etc., and a brief description of each panel given in the figure legend. When using histology figures, the stain type and magnification level must be included in the legend.

Only figures of excellent quality will be considered for publication. The Journal will publish color photographs free of charge subject to editorial approval. When an individual is identifiable in a photograph written permission must be obtained (see Section 5 ‘Ethics’ below).

Authors are themselves responsible for obtaining permission to reproduce previously published figures, tables and illustrations, for which they do not own the copyright. Permissions must be obtained from the original publisher or copyright holder and the evidence of permission should be provided to the Editorial Office upon submission. Proper acknowledgement of the original source, in the form of a copyright notice, should be included in the table/figure legends.


Supplementary materials

Supplementary materials, e.g., appendices, figures, tables, datasets, and audio-visual files, may be uploaded during submission as helpful additional content for understanding and interpreting the manuscript. These supplements will be considered for inclusion in the online-only version of the article during the review process. The amount of online-only material should be limited and justified. Online-only supplementary materials will undergo editorial and peer review with the main manuscript. Note that supplementary material is ONLY allowed for the following manuscript categories: Review Articles and Original Articles.


References
References should be in Vancouver format and appear as consecutive, unbracketed superscript numbers in the text, e.g. ‘in our previous reports1,2 and those of Smith et al.3–5’ and should be listed numerically in the reference list at the end of the article.

Format references as below, using standard (Medline) abbreviations for journal titles. When there are more than six authors, include the first six authors followed by et al.

  1. de Berker DAR, Baran R, Dawber RPR. The Nail in Dermatological Diseases. In:Baran and Dawber's Diseases of the Nails and their Management(Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti, A, eds), 3rd edn. Oxford: Blackwell Science Ltd., 2001: 172–92.
    2. Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007; 32: 23–7.
    3. Graham-Brown R, Burns T. Lecture Notes: Dermatology. Oxford: Wiley-Blackwell, 2006.
    4. Smith A. (1999) Select committee report into social care in the community [WWW document]. URL http://www.dhss.gov.uk/reports/report015285.html [accessed on 7 November 2003].

5.DECLARATIONS

Original Publication
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.


Conflicts of Interest

Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.


Ethics

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. A statement describing explicitly the ethical background to the studies being reported should be included in all manuscripts in the Materials and Methods section. Ethics committee or institutional review board approval should be stated.

Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.


Authorship

All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.

Committee on Publication Ethics (COPE)
As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in IJD; mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the duty of the Editor to report this to COPE. COPE may recommend that action be taken, including but not exclusive to, informing the authors' professional regulatory body and/or institution of such a dereliction.

The website for COPE may be accessed at: http://www.publicationethics.org.uk

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

 
Artificial Intelligence

Policy on the use of AI in scientific writing

Where authors use generative artificial intelligence and AI-assisted technologies in the writing process, authors should only use these technologies to draw insights from data as part of the research phase, and in order to improve the legibility and linguistic properties of the submission.

Application of AI technology should be done with human oversight and control, and authors should meticulously review and edit the results prior to submission. Source criticism must at all times be practiced, as AI can often generate output that may prove misleading, fragmentary or biased. AI and AI-assisted technologies should not be listed nor cited as an author or co-author.


Declaration of generative AI in scientific writing
 

Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the research and writing process by following the instructions below. The declarative statement will appear in the published work before the References list. Ultimately, the author is responsible and accountable for the contents of the work submitted. Each author and co-author is accountable for preserving the accuracy, integrity and originality of their work.


Disclosure instructions

Please place the below statement in a new section entitled ‘Declaration of the use of Generative AI and AI-assisted technologies in the research and writing process’.

Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON FOR UTILIZING AI TOOL/SERVICE]. Following the use of this tool/service, the author(s) reviewed and edited the content thoroughly and hereby declare(s) full responsibility for the authenticity of the contents of this publication.

This declaration does not apply to the use of basic tools for checking grammar, spelling, references and the like. If there is nothing to disclose, there is no need to add this declarative statement.


6.ADDITIONAL INFORMATION ON ACCEPTANCE

Author services
Author Services enables authors to track their article—once it has been accepted—through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript.

Wiley’s Author Services are specifically tailored to support you throughout the manuscript preparation process, from the writing and researching stages to the title’s ultimate distribution. Wiley Editing Services offers expert help with article preparation, including translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design. Using advanced algorithms, Wiley’s Manuscript Language Checker will provide you with a language quality score and recommend the best service to get your manuscript ready and accepted. Wiley’s inexhaustible supply even comprises a Journal Finder engine that helps you find the fitting journal to publish with by searching other relevant titles related to your own research. Share your aims and objectives and receive curated recommendations and expert reports through Wiley’s Journal Recommendation Service. Browse Wiley’s Online Library for every publication accessible on file. Additionally, Wiley Researcher Academy, an online on-demand learning program, facilitates the development of your article writing skills and guides you along the publishing process.

Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.


For authors signing the copyright transfer agreement

If the open access in hybrid titles option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below: CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp 


For authors choosing open access in hybrid titles

If the open access in hybrid titles option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial - NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

If you select the open access in hybrid titles option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement .

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp  and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html


Proofs

The corresponding author will receive an email alert containing a link to a web site. Please answer all queries and update the text as required.


Early View

IJD is covered by the Publisher's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed or online issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found online at http://www.doi.org/faq.html.


Offprints

Free access to the final PDF offprint of your article will be available via Author Services only.

Should you wish to purchase additional copies of your article, please click on the link and follow the instructions provided: 
www.sheridan.com/wiley/eoc


Note to NIH Grantees

Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see http://www.wiley.com/go/nihmandate.

 
Contacting the Editorial Office

Prof. Dr. Lajos Kemény
Elected Editor-in-Chief
International Journal of Dermatology
[email protected]
Department of Dermatology and Allergology
University of Szeged